MedPath

The efficacy of an Iranian traditional medicinal drug in the treatment of cutaneous lesions of Pemphigus Vulgaris.

Not Applicable
Conditions
Pemphigus vulgaris.
Pemphigus vulgaris
Registration Number
IRCT2013120815720N1
Lead Sponsor
Tehran University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

patients who has confirmed Pemphigus vulgaris in clinical manifestation and pathology and direct immunofluorescence; who has been admitted for the first time or in the relapse of disease; having two symmetrical lesions on the trunk or extremities; signing of informed consent.
exclusion criteria:
Pregnant or nursing patients; having drug sensitivity; face lesions; infected lesions.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diameter of ?skin pemphigus lesions. Timepoint: 0, 15, 30. Method of measurement: ruler (mm).
Secondary Outcome Measures
NameTimeMethod
Epithelization index. Timepoint: 0, 15, 30. Method of measurement: Maximum diameter at the baseline - Maximum diameter at the end of study)/ Maximum diameter at the baseline * 100.
© Copyright 2025. All Rights Reserved by MedPath